Page last updated: 2024-10-21

5,7-dichlorokynurenic acid and Idiopathic Parkinson Disease

5,7-dichlorokynurenic acid has been researched along with Idiopathic Parkinson Disease in 1 studies

5,7-dichlorokynurenic acid: potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ossowska, K1
Lorenc-Koci, E1
Konieczny, J1
Wolfarth, S1

Other Studies

1 other study available for 5,7-dichlorokynurenic acid and Idiopathic Parkinson Disease

ArticleYear
The role of striatal glutamate receptors in models of Parkinson's disease.
    Amino acids, 1998, Volume: 14, Issue:1-3

    Topics: Animals; Corpus Striatum; Disease Models, Animal; Dizocilpine Maleate; Electromyography; Excitatory

1998